Citigroup
OCEA

Citigroup’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Citigroup’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-142
Closed -$8 – 5973
2025
Q1 		$8 Sell
142
-4,658
-97% -$1.11K ﹤0.01% 5498
2024
Q4 		$2.65K Buy
4,800
+4,009
+507% +$3.16K ﹤0.01% 5532
2024
Q3 		$775 Sell
791
-2,304
-74% -$2.47K ﹤0.01% 5461
2024
Q2 		$3.78K Buy
3,095
+687
+29% +$1.17K ﹤0.01% 5288
2024
Q1 		$9.11K Buy
2,408
+1,020
+73% +$1.92K ﹤0.01% 5225
2023
Q4 		$916 Buy
1,388
+1,380
+17,250% +$1.89K ﹤0.01% 5471
2023
Q3 		$32 Sell
8
-2,575
-100% -$11.8K ﹤0.01% 5561
2023
Q2 		$15.5K Buy
+2,583
New +$15.1K ﹤0.01% 5004

Other funds holding OCEA

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

Citigroup's OCEA Position: Q2 2025 in Review

Citigroup sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 142 shares — an estimated $8 sold.

Citigroup first reported a position in OCEA in Q2 2023 and held it in 8 quarters. The position peaked at $15.5K in Q2 2023. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

  • Citigroup reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • Citigroup sold 142 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $8.
  • Citigroup first reported a position in Ocean Biomedical, Inc. Common Stock in Q2 2023 and held it in 8 quarters.
  • Citigroup's Ocean Biomedical, Inc. Common Stock position peaked at $15.5K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.